CN1823843A - Child ammonia phenol alkyl amine affervescent tablet and its preparation method - Google Patents

Child ammonia phenol alkyl amine affervescent tablet and its preparation method Download PDF

Info

Publication number
CN1823843A
CN1823843A CNA2005101205211A CN200510120521A CN1823843A CN 1823843 A CN1823843 A CN 1823843A CN A2005101205211 A CNA2005101205211 A CN A2005101205211A CN 200510120521 A CN200510120521 A CN 200510120521A CN 1823843 A CN1823843 A CN 1823843A
Authority
CN
China
Prior art keywords
child
affervescent
tablet
alkyl amine
mesh sieves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005101205211A
Other languages
Chinese (zh)
Inventor
刘春�
龙新华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2005101205211A priority Critical patent/CN1823843A/en
Publication of CN1823843A publication Critical patent/CN1823843A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An infantile effervescent tablet of aminophenol alkylamine is prepared proportionally from p-acetylaminopenol, adamantanamine hydrochloride, coffin, artificial bezoar, chlorpheniramine maleate, effervescent agent, filler, flavouring and lubricant.

Description

Child ammonia phenol alkyl amine affervescent tablet and preparation method thereof
Technical field
The present invention relates to a kind of child ammonia phenol alkyl amine affervescent tablet of using modern formulation treatment children's Common Cold and preparation method thereof.
Background technology
Child ammonia phenol alkane effervescent tablet is an antipyretic-antalgic class compound recipe Western medicine, be used for the nasal obstruction that Common Cold causes, throat pain, headache, diseases such as heating, the national drug standards disclose this particulate prescription, character, differentiate, check, standards such as assay, clinical practice for many years proves, this granule has good antipyretic-antalgic effect, the oral administration effervescing sheet is novel dosage form, be with a kind of tablet of effervescent material as disintegrating agent, this preparation is specially adapted to the child, the patient of the old people and the solid preparation of can not swallowing, again because of identical with granule be to take with the solution form, drug effect is rapid, the bioavailability height, and compare with liquid preparation, carry more conveniently, receive patient's welcome greatly.
Summary of the invention
The object of the present invention is to provide a kind of child ammonia phenol alkyl amine affervescent tablet and preparation method thereof, its taking convenience, mouthfeel are good.
The present invention is achieved like this, and it comprises principal agent and adjuvant, it is characterized in that principal agent is formulated by the following raw materials in part by weight medicine:
Acetaminophen 100 amantadine hydrochlorides 40 caffeine 6
Artificial Calculus Bovis's 4 chlorphenamine maleate 0.8
Adjuvant is formulated by following substances in parts by weight:
Effervescent 160~240 filleies 80~120
Correctives 32~48 lubricants 2~6
The acid source of described effervescent is a citric acid, and the carbon dioxide source of effervescent is a sodium bicarbonate, and filler is a lactose, and correctives is a protein sugar, and lubricant is a sodium benzoate.Its preparation method is: get acetaminophen, amantadine hydrochloride, caffeine, chlorphenamine maleate and be ground into fine powder, cross 100 mesh sieves; Other gets the artificial Calculus Bovis and is ground into impalpable powder, crosses 325 mesh sieves; The abundant mixing of above-mentioned powder, standby.Get the lactose of above-mentioned 1/2 medicated powder of measuring, 1/2 amount, the protein sugar and the citric acid of 1/2 amount, mixing is granulated with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, and is dry below 60 ℃, gets granulates; Other gets remaining above-mentioned medicated powder, lactose, protein sugar and sodium bicarbonate, and mixing is granulated with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, and is dry below 60 ℃, sprays into essence, gets the alkali granule.Get above-mentioned granulates and alkali granule, the adding sodium benzoate is an amount of, 24 mesh sieve granulate, and mixing is pressed into 1000, promptly.
The present invention is dosage form improvement on existing particulate basis, uses easy to carryly, is clinical welcome and safe and effective medicine.
The specific embodiment
Embodiment one, get acetaminophen 100g, amantadine hydrochloride 40g, caffeine 6g, chlorphenamine maleate 0.8g are ground into fine powder, cross 100 mesh sieves; Other gets artificial Calculus Bovis 4g and is ground into impalpable powder, crosses 325 mesh sieves; The abundant mixing of above-mentioned powder, standby.Get the protein sugar and the 50g citric acid of above-mentioned 1/2 medicated powder of measuring, 49g lactose, 20g amount, mixing is granulated with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, and is dry below 60 ℃, gets granulates; Other gets remaining above-mentioned medicated powder, lactose, protein sugar and sodium bicarbonate, and mixing is granulated with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, and is dry below 60 ℃, sprays into essence, gets the alkali granule.Get above-mentioned granulates and alkali granule, the adding sodium benzoate is an amount of, 24 mesh sieve granulate, and mixing is pressed into 1000, promptly.

Claims (3)

1, a kind of child ammonia phenol alkyl amine affervescent tablet, it comprises principal agent and adjuvant, it is characterized in that principal agent is formulated by the following raw materials in part by weight medicine:
Acetaminophen 100 amantadine hydrochlorides 40 caffeine 6
Artificial Calculus Bovis's 4 chlorphenamine maleate 0.8
Adjuvant is formulated by following substances in parts by weight:
Effervescent 160~240 filleies 80~120
Correctives 32~48 lubricants 2~6
2, child ammonia phenol alkyl amine affervescent tablet according to claim 1, the acid source that it is characterized in that described effervescent is a citric acid, and the carbon dioxide source of effervescent is a sodium bicarbonate, and filler is a lactose, and correctives is a protein sugar, lubricant is a sodium benzoate.
3, the described child ammonia phenol alkyl amine affervescent tablet preparation method of a kind of claim 1 is characterized in that processing step is: get acetaminophen, amantadine hydrochloride, caffeine, chlorphenamine maleate and be ground into fine powder, cross 100 mesh sieves; Other gets the artificial Calculus Bovis and is ground into impalpable powder, crosses 325 mesh sieves; The abundant mixing of above-mentioned powder, standby.Get the lactose of above-mentioned 1/2 medicated powder of measuring, 1/2 amount, the protein sugar and the citric acid of 1/2 amount, mixing is granulated with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, and is dry below 60 ℃, gets granulates; Other gets remaining above-mentioned medicated powder, lactose, protein sugar and sodium bicarbonate, mixing, granulate with 5% 30 POVIDONE K 30 BP/USP, 30 alcoholic solution, 24 mesh sieves, dry below 60 ℃, spray into essence, get the alkali granule, get above-mentioned granulates and alkali granule, the adding sodium benzoate is an amount of, 24 mesh sieve granulate, mixing is pressed into 1000.
CNA2005101205211A 2005-12-23 2005-12-23 Child ammonia phenol alkyl amine affervescent tablet and its preparation method Pending CN1823843A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2005101205211A CN1823843A (en) 2005-12-23 2005-12-23 Child ammonia phenol alkyl amine affervescent tablet and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2005101205211A CN1823843A (en) 2005-12-23 2005-12-23 Child ammonia phenol alkyl amine affervescent tablet and its preparation method

Publications (1)

Publication Number Publication Date
CN1823843A true CN1823843A (en) 2006-08-30

Family

ID=36934783

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005101205211A Pending CN1823843A (en) 2005-12-23 2005-12-23 Child ammonia phenol alkyl amine affervescent tablet and its preparation method

Country Status (1)

Country Link
CN (1) CN1823843A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102879517A (en) * 2012-10-08 2013-01-16 葵花药业集团(衡水)得菲尔有限公司 Quality testing method for compound paracetamol and amantadine hydrochloride granules
CN103564593A (en) * 2012-08-02 2014-02-12 佳格食品股份有限公司 Effervescent tablets with enhanced refreshing effect
CN104041908A (en) * 2014-07-02 2014-09-17 菏泽尧舜牡丹生物科技有限公司 Preparation method of peony pollen effervescent tablet
CN115300468A (en) * 2022-08-08 2022-11-08 广西纯正堂制药有限公司 Pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate orally disintegrating tablets and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103564593A (en) * 2012-08-02 2014-02-12 佳格食品股份有限公司 Effervescent tablets with enhanced refreshing effect
CN105412041A (en) * 2012-08-02 2016-03-23 佳格食品股份有限公司 Effervescent tablet with energizing enhancing effect
CN102879517A (en) * 2012-10-08 2013-01-16 葵花药业集团(衡水)得菲尔有限公司 Quality testing method for compound paracetamol and amantadine hydrochloride granules
CN104041908A (en) * 2014-07-02 2014-09-17 菏泽尧舜牡丹生物科技有限公司 Preparation method of peony pollen effervescent tablet
CN115300468A (en) * 2022-08-08 2022-11-08 广西纯正堂制药有限公司 Pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate orally disintegrating tablets and preparation method thereof
CN115300468B (en) * 2022-08-08 2024-01-30 广西纯正堂制药有限公司 Pediatric paracetamol, chlorphenamine maleate orally disintegrating tablet and preparation method thereof

Similar Documents

Publication Publication Date Title
JP7284241B2 (en) Fast-Acting Plant-Derived Pharmaceutical Compounds and Nutraceuticals
EP1750677B1 (en) Oral therapeutic compound delivery system
US20220133685A1 (en) Fast-acting plant-based medicinal compounds and nutritional supplements
US20200254041A1 (en) Rapid onset and extended action plant-based and synthetic cannabinoid formulations
JP7281815B2 (en) Pharmaceutical compounds and nutritional supplements
US20240000879A1 (en) Herbal compositions with improved bioavailability
KR101203186B1 (en) Taste-masked pharmaceutical composition for oral administration and a process for the preparation thereof
CN1823843A (en) Child ammonia phenol alkyl amine affervescent tablet and its preparation method
JP4377564B2 (en) Composition for internal use
AU2019306315B2 (en) Pharmaceutical composition in the form of a chewable tablet of diosmin or of a flavonoid moiety
CN1985807A (en) Compound Desloratadine-Ambroxol oral disintegrated tablet and its preparing method
CN100427088C (en) Paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral cavity disintegration tablet for treating cold and preparation method thereof
CN101919799B (en) Novel sustained-release transdermal medicament delivery system
CN1907274A (en) Pharmaceutical preparation such as hemsleyadine dispersable tablet et al. and preparation method thereof
CN1314399C (en) Child metho kahuangmin effervescent granules and its making method
KR100815029B1 (en) Doxophylline sustained-release dosage form
CN112535670A (en) Agomelatine dispersible tablet and preparation method thereof
CN101766576A (en) Buccal tablet with fentanyl as main active component and preparation method thereof
CN104042615A (en) Pharmaceutical composition containing desloratadine and dimemorfan phosphate
CN102038655A (en) Pain-relieving chewing tablet and preparation method of the same
CN101756933A (en) Prescription, preparation method and application of effervescent tablets containing dimemorfan

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20060830